-
1
-
-
0030756151
-
Monoallelic p53 deletion in chronic lymphocytic leukemia detected by interphase cytogenetics
-
Amiel A, Arbov L, Manoy Y. Monoallelic p53 deletion in chronic lymphocytic leukemia detected by interphase cytogenetics. Cancer Genet Cytogenet 1997; 97: 97-100.
-
(1997)
Cancer Genet Cytogenet
, vol.97
, pp. 97-100
-
-
Amiel, A.1
Arbov, L.2
Manoy, Y.3
-
2
-
-
0035865516
-
Apoptosis of tumoral and nontumoral lymphoid cells is induced by both mdm2 and p53 antisense oligodeoxynucleotides
-
Capoulade C, Lluis MM, Karine C. Apoptosis of tumoral and nontumoral lymphoid cells is induced by both mdm2 and p53 antisense oligodeoxynucleotides. Blood 2001; 97: 1043-9.
-
(2001)
Blood
, vol.97
, pp. 1043-1049
-
-
Capoulade, C.1
Lluis, M.M.2
Karine, C.3
-
3
-
-
0031755161
-
A comprehensive system to explore p53 mutations
-
Furuwatari C, Yagi A, Yamagami O. A comprehensive system to explore p53 mutations. Am J Clin Pathol 1998; 110: 368-73.
-
(1998)
Am J Clin Pathol
, vol.110
, pp. 368-373
-
-
Furuwatari, C.1
Yagi, A.2
Yamagami, O.3
-
4
-
-
0025319412
-
Chromosome aberrations in B-cell chronic lymphocytic leukemia
-
Juliusson G, Gahrton G. Chromosome aberrations in B-cell chronic lymphocytic leukemia. Cancer Genet Cytogenet 1990; 45: 143-60.
-
(1990)
Cancer Genet Cytogenet
, vol.45
, pp. 143-160
-
-
Juliusson, G.1
Gahrton, G.2
-
5
-
-
0025173845
-
P53: Oncogene or anti-oncogene?
-
Lane DP, Benchimal S. P53: oncogene or anti-oncogene? Genes Dev 1990; 4: 1-8.
-
(1990)
Genes Dev
, vol.4
, pp. 1-8
-
-
Lane, D.P.1
Benchimal, S.2
-
6
-
-
0024387728
-
Mutations in the p53 gene occur in diverse human tumour types
-
Nigro JM, Baker SJ, Preisinger AC. Mutations in the p53 gene occur in diverse human tumour types. Nature 1989;342:705-7.
-
(1989)
Nature
, vol.342
, pp. 705-707
-
-
Nigro, J.M.1
Baker, S.J.2
Preisinger, A.C.3
-
7
-
-
0028901763
-
Clinical significance of p53 mutations in newly diagnosed Burkitt's lymphoma and acute lymphoblastic leukemia: A report of 48 cases
-
Preudhomme C, Dervile I, Wattel E. Clinical significance of p53 mutations in newly diagnosed Burkitt's lymphoma and acute lymphoblastic leukemia: a report of 48 cases. J Clin Oncol 1995; 13: 812-20.
-
(1995)
J Clin Oncol
, vol.13
, pp. 812-820
-
-
Preudhomme, C.1
Dervile, I.2
Wattel, E.3
-
8
-
-
0025818270
-
Mutant p53 detected in a majority of Burkitt lymphoma cell lines by monoclonal antibody Pab240
-
Winman KG, Magnusson KP, Ramqvist T, Klein G. Mutant p53 detected in a majority of Burkitt lymphoma cell lines by monoclonal antibody Pab240. Oncogene 1991; 6: 1633-9.
-
(1991)
Oncogene
, vol.6
, pp. 1633-1639
-
-
Winman, K.G.1
Magnusson, K.P.2
Ramqvist, T.3
Klein, G.4
-
9
-
-
0028943706
-
Interaction of p53 with its concensus DNA-binding site
-
Wong Y, Schwedes JF, Parks D, Mann K, Tegtmeyer P. Interaction of p53 with its concensus DNA-binding site. Mol Cell Biol 1995; 15: 2157-65.
-
(1995)
Mol Cell Biol
, vol.15
, pp. 2157-2165
-
-
Wong, Y.1
Schwedes, J.F.2
Parks, D.3
Mann, K.4
Tegtmeyer, P.5
-
10
-
-
0038129991
-
Combination of nonradioisotopic techniques as an efficient screening method to detect p53 mutations
-
18-20 pp
-
Yoshifumi O, Furuwatari C. Combination of nonradioisotopic techniques as an efficient screening method to detect p53 mutations. Biotech Lab International 1999; 18-20 pp.
-
(1999)
Biotech Lab International
-
-
Yoshifumi, O.1
Furuwatari, C.2
|